Mallinckrodt (MNKKQ)

OTC Markets
0.27
+0.01(+3.25%)
After Hours
0.27
0.00(1.81%)
- Real-time Data
  • Volume:
    245,974
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    0.26 - 0.27

MNKKQ Overview

Prev. Close
0.26
Day's Range
0.26 - 0.27
Revenue
2.64B
Open
0.26
52 wk Range
0.11 - 3.66
EPS
-12.51
Volume
245,974
Market Cap
22.87M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
416,014
P/E Ratio
-
Beta
3.42
1-Year Change
-90.88%
Shares Outstanding
84,709,114
Next Earnings Date
Aug 10, 2021
What is your sentiment on Mallinckrodt?
or
Market is currently closed. Voting is open during market hours.

Mallinckrodt News

Mallinckrodt Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell

Mallinckrodt Company Profile

Mallinckrodt Company Profile

Industry
Major Drugs
Employees
3100

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

Read More
  • What about you, johns, why so afraid to buy more? Coz you are all cuckolds and school boys?
    0
    • I gave you a like)))
      0
  • Good morning! target new 15.70$
    1
    • why mnkkq charge 50 $ tomorrow ?
      0
      • why mnkkq charge 50 $ tomorrow ?
        0
        • Check NMTR, it has a lead medication called larazotide currently at phase 111 clinical trial for celiac disease with the potential of using it to reduce covid-induced respiratory symptoms! Buy and enjoy later analyst consensus price target at $6 but currently trading in pre market at $1.9
          2
          • What happened here? Any news?
            0
            • chapter 11
              3
              • https://finance.yahoo.com/news/buxton-helmsley-group-announces-sufficient-200200706.html
                0
                • is this news good or Bad for this stock?
                  0
                • it gives a hope
                  0
              • Mallinckrodt Receives Approval in Japan of the CELLEX® Extracorporeal Photopheresis System for Treatment of Chronic Graft Versus Host Disease
                0
                • This is going to explode shortly from now
                  0
                  • what does it mean??? could u explain???
                    0
                  • it mean this.
                    0
                • Why is this company is trading so low?! Does it have future?
                  0
                  • buy!!!
                    0
                    • AVGR +46%
                      0
                      • Heading straight to above 5usd per share before end of January 2021!
                        0
                        • I hope that you bought at >$.4 if you are so confident
                          0
                      • It's a bankrupt company: https://seekingalpha.com/news/3621280-mallinckrodt-files-for-chapter-11-for-opioid-settlement-and-debt-reduction The shares will be cancelled at the end of the bankruptcy procedure, do a little research before buying a share.
                        1
                        • Never. That's old news since 2months ago.This is going to beyond 5usd per share before the end of January 2021!
                          0
                        • 0
                      • This wont disappear. Invest $500 its going to make you $12k within 12 months.
                        0
                        • VelerofodiSs Valesi also had a lot in NIO when it was at $2
                          0
                        • Teach me I am New
                          0
                        • 10% down ... I can't believe it..how you believe to go?
                          0
                      • Hello, Is it tades somewhere on OTC? What is the ticker please? The company's site is no more operating?
                        0
                        • MNKKQ
                          0
                      • a go ? or no?
                        1
                        • legit
                          0
                          • lawyers killed this company and its investors
                            0
                            • Bankruptcy... Lesson learned when you play with fire... You get burnt, with no exceptions... "equity holders and non-guaranteed unsecured noteholders are expected to receive no recovery." Read more at: https://thefly.com/n.php?id=3173085
                              2
                              • is it stopped?
                                0
                                • I'm glad I sold 3 months ago, I saved a bunch of money.
                                  2
                                  • omg u r so clever that u need to come to this forum and post that.. here, the peanut for you
                                    1
                                  • ana kw Thanks *****
                                    0
                                  • I don't know why your name got with the character *, I guess upper case?
                                    0
                                • bounce is quite possible
                                  2
                                  • No
                                    1
                                • How much
                                  0
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.